Christine Simmon joined the Association for Accessible Medicines (AAM) in 2012 as the Senior Vice President of Policy & Strategic Alliances. She is Executive Director of AAM’s Biosimilars Council.
In her current role, Christine is responsible for leading policy development and issues management for AAM, directing the Biosimilars Council, and building relationships with strategic partners in the health care sector, including patient advocacy groups.
Christine had previously served as Vice President of Policy, Public Affairs & Development at AAM from 2002 to 2006. Before rejoining the association, she was the Senior Director of Public Policy for CVS Caremark, where she was the policy lead for the integrated retail, convenient care clinic and pharmacy benefit manager enterprise at both the state and federal levels. Previously, Christine was a Senior Policy Analyst at BlueCross BlueShield Association, where she helped position the insurer as a leading voice on pharmaceutical cost and safety issues.
Christine received her J.D. from Georgetown University Law Center and her B.A. in American Studies from Georgetown University.